We also demonstrated that just a single dose of Anti-C5 antibody ameliorates not only hepatic ischemia/reperfusion injury (16) but also fulminant hepatitis/acute liver failure in murine models (17), dominantly via the C5a-mediated cascade. The gene discussed is C5; the disease is acute liver failure.